ARDX Stock Analysis: Buy, Sell, or Hold?
ARDX - Ardelyx, Inc.
$4.98
0.03 (0.61%)
▲
5d:
-1.58%
30d:
-5.5%
90d:
-27.62%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Smart Money Accumulation
None View Scanner →
Strength: 8.6/10
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -20.2% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -20.2% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.71
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.51
41.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $4.98, which is considered oversold relative to its 30-day fair value range of $4.99 to $5.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.7) compared to its historical average (19.0). Remarkably, the market is currently pricing in an annual earnings decline of 20.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is currently testing key support at $4.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.30 (+227.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is currently testing key support at $4.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.30 (+227.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.99 -
$5.43
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 227.3% below Wall St target ($16.30)
Trading Range Analysis
30-Day Trading Range
$4.99 -
$5.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.88
Resistance Level
$5.21
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.67
Wall Street Target
$16.30
(+227.3%)
Revenue Growth (YoY)
27.5%
Profit Margin
-13.6%
Valuation Discount vs History
-20.2% cheaper
PE vs Historical
9.7 vs 19.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.2%
(market-implied from PE analysis)
1-Year Target
$4.48
(-10%)
2-Year Target
$4.03
(-19%)
3-Year Target
$3.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→19)
$7.13
(+43%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 19.0
Stabilization Target:
$9.79
(+96.5%)
PE Expansion Potential:
+96.5%
Share & Embed Analysis
Last updated: August 03, 2026 7:11 PM ET
Data refreshes hourly during market hours. Next update: 8:11 PM
Data refreshes hourly during market hours. Next update: 8:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab
SELL
41666 shares
2026-03-16
David M Mott
BUY
333333 shares
2026-02-20
Susan Hohenleitner
SELL
2033 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
